In the present study, we established a new normal range of serum ALT and examined its ability to identify patients with hepatitis B and nonalcoholic fatty liver disease (NAFLD) and those at low risks for liver diseases in Chinese Han population. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.